Bisaro Paul 4

4 · Keenova Therapeutics plc · Filed Jun 4, 2026

AI-generated summary of this filing

Updated Jun 4, 2026

Keenova Therapeutics Director Paul Bisaro Exercises RSUs; Shares Withheld

What Happened

Paul Bisaro, a director of Keenova Therapeutics plc, had restricted stock units (RSUs) settled on June 2, 2026. The filing shows 2,685 RSUs converted into ordinary shares.
Of the shares related to the vesting, 619 shares were withheld to satisfy tax withholding obligations, and 2,197 RSUs were forfeited back to the issuer under an agreement in exchange for a payment from the issuer to help cover tax obligations. One reporting line lists an exercise/conversion with a $0.00 price for the disposition entry.

Key Details

Transaction date: June 2, 2026; Form 4 filed June 4, 2026 (within the typical 2-business-day reporting window).
Reported entries: 2,685 RSUs converted to shares (M); 619 shares withheld for taxes (F); 2,197 RSUs forfeited/disposed to issuer (D). One conversion/disposition line shows $0.00 price.
Shares owned after the transaction: not specified in the filing.
Notable footnotes: RSUs settled 1-for-1 into ordinary shares (F1); withholding based on a percentage because Keenova’s shares are not listed/quoted on a recognized market (F2); forfeiture of 2,197 RSUs in exchange for issuer payment to facilitate tax obligations (F3); RSUs granted Aug 14, 2025 and vesting schedule noted (F4, F5).
Filing also serves as notice to the issuer under Part V of the Companies Act 2014 (remark in filing).

Context

This is an equity-compensation event (RSU vesting and related tax/forfeiture actions), not an open-market buy or sale. Such transactions are typically routine and relate to compensation and tax settlement rather than a direct signal of insider sentiment.
For retail investors: purchases are often more informative than routine vesting; here the key items are the withholding and the unusual forfeiture+payment arrangement (issuer assisted with tax obligations), which are administrative/tax-related rather than market-directional.

Form 4

Period: 2026-06-02

Director

Transactions

Exercise/Conversion
Ordinary Shares
[F1]
2026-06-02+2,685→ 6,863 total
Tax Payment
Ordinary Shares
[F2]
2026-06-02−619→ 6,244 total
Disposition to Issuer
Restricted Stock Units
[F3][F5][F4]
2026-06-02−2,197→ 45,028 total
→ Ordinary Shares (2,197 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-06-02−2,685→ 42,343 total
→ Ordinary Shares (2,685 underlying)

Footnotes (5)

[F1]Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
[F2]The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.
[F3]The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest.
[F4]The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.
[F5]The number of RSUs forfeited is based on a percentage.

Signature

/s/ Mark Tyndall, Attorney-in-Fact|2026-06-04

1 file